— Know what they know.
Not Investment Advice

OCS NASDAQ

Oculis Holding AG
1W: +4.5% 1M: -13.6% 3M: -27.8% YTD: -60.9% 1Y: -63.1% 3Y: -21.7% 5Y: -19.0%
$7.83
-0.13 (-1.63%)
 
Weekly Expected Move ±7.3%
$7 $7 $8 $8 $9
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 35 · $482.2M mcap · 40M float · 0.778% daily turnover · Short 38% of daily vol
Credit Risk of going bust: lower than 70% of companies Debt: 0.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down 99.9%), Oculis Holding AG would be worth roughly what it owes.
Total debt $3.1M against a stock market value of $482.2M.
Distance to default 7.57 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.5M (short-term plus half of long-term), stock volatility 73.3%; Altman Z'' 5.17. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
$0 +100.0% ▲
Operating Income
-$79M -8.1% ▼
Net Income
-$95M -10.2% ▼
EPS (Diluted)
$-1.81 +14.6% ▲
EBITDA
-$79M -8.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$686K$0
YoY Growth-100.0%+0.0%+0.0%+0.0%-100.0%
Cost of Revenue$0$0$0$52M$0
Gross Profit$0$0$0-$51M$0
Gross Margin———-7492.3%—
R&D Expenses$10M$22M$29M$52M$55M
SG&A Expenses$4M$7M$15M$22M$25M
Operating Expenses$13M$32M$81M$22M$79M
Operating Income-$13M-$32M-$81M-$73M-$79M
Operating Margin———-10671.1%—
Interest Expense$5M$6M$1M$0$796K
Income Before Tax-$19M-$39M-$89M-$86M-$95M
Tax Expense$27K$55K$107K-$160K$178K
Net Income-$19M-$39M-$89M-$86M-$95M
Net Margin———-12503.9%—
EPS (Diluted)$-0.57$-1.18$-2.97$-2.12$-1.81
EBITDA-$13M-$32M-$87M-$73M-$79M
Shares Outstanding33M33M30M40M52M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms